Align Technology, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US0162551016
USD
156.84
5.91 (3.92%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.36 M

Shareholding (Mar 2025)

FII

25.60%

Held by 403 FIIs

DII

25.71%

Held by 59 DIIs

Promoter

0.30%

How big is Align Technology, Inc.?

22-Jun-2025

As of Jun 18, Align Technology, Inc. has a market capitalization of $12.7 billion, with net sales of $3.98 billion and net profit of $409.56 million over the latest four quarters.

As of Jun 18, Align Technology, Inc. has a market capitalization of 12,696.44 million, categorizing it as a Large Cap company.<BR><BR>As of Jun 18, the sum of Net Sales for the latest four quarters is 3,980.84 million, while the sum of Net Profit for the same period is 409.56 million.<BR><BR>As of Dec 24, the reporting period shows Shareholder's Funds at 3,851.99 million and Total Assets at 6,214.60 million.

Read More

What does Align Technology, Inc. do?

22-Jun-2025

Align Technology, Inc. designs and markets clear aligner therapy and digital services for dentistry, with a market cap of approximately $12.7 billion. As of March 2025, it reported net sales of $979 million and a net profit of $93 million.

Overview:<BR>Align Technology, Inc. designs, manufactures, and markets a system of clear aligner therapy and digital services used in dentistry, operating within the Pharmaceuticals & Biotechnology industry and classified as a large-cap company.<BR><BR>Financial Snapshot:<BR>Net Sales: 979 Million (Quarterly Results - Mar 2025)<BR>Net Profit: 93 Million (Quarterly Results - Mar 2025)<BR>Market cap: USD 12,696.44 Million (Large Cap)<BR><BR>Key Metrics:<BR>P/E: 29.00<BR>Dividend Yield: 0.00%<BR>Debt Equity: -0.22<BR>Return on Equity: 11.95%<BR>Price to Book: 3.35<BR><BR>Contact Details:<BR>Address: 2820 Orchard Pkwy, SAN JOSE CA: 95134-2019<BR>Tel: ['1 408 4701000', '1 408 4701150']<BR>Fax: 1 408 4701010<BR>Website: http://www.aligntech.com/

Read More

Who are in the management team of Align Technology, Inc.?

22-Jun-2025

As of March 2022, the management team of Align Technology, Inc. includes CEO Joseph Hogan, Independent Chairman Charles Larkin, and several independent directors, including Thomas Prescott, Kevin Dallas, Joseph Lacob, George Morrow, and Anne Myong, who oversee the company's operations and strategy.

As of March 2022, the management team of Align Technology, Inc. includes the following individuals:<BR><BR>- Mr. Charles Larkin, Independent Chairman of the Board<BR>- Mr. Joseph Hogan, President, Chief Executive Officer, and Director<BR>- Mr. Thomas Prescott, Director<BR>- Mr. Kevin Dallas, Independent Director<BR>- Mr. Joseph Lacob, Independent Director<BR>- Mr. George Morrow, Independent Director<BR>- Ms. Anne Myong, Independent Director<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

Read More

Should I buy, sell or hold Align Technology, Inc.?

22-Jun-2025

Is Align Technology, Inc. technically bullish or bearish?

20-Sep-2025

As of August 25, 2025, Align Technology, Inc. is in a bearish trend with weak strength, indicated by bearish MACD readings and moving averages, despite a bullish RSI, and has underperformed the S&P 500 with a year-to-date return of -36.42%.

As of 25 August 2025, the technical trend for Align Technology, Inc. has changed from mildly bearish to bearish. The current stance is bearish with weak strength, indicated by bearish MACD readings on both weekly and monthly time frames, and a bearish daily moving average. The Bollinger Bands are also showing a bearish trend on the monthly level. Although the RSI is bullish on both weekly and monthly time frames, this is overshadowed by the overall bearish indicators. Additionally, the stock has significantly underperformed compared to the S&P 500 across multiple periods, with a year-to-date return of -36.42% versus the S&P 500's 12.22%.

Read More

Is Align Technology, Inc. overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, Align Technology, Inc. is considered overvalued with a P/E ratio of 29 compared to a peer average of 20.46, and its poor year-to-date performance of -37.44% further supports this assessment.

As of 17 October 2025, the valuation grade for Align Technology, Inc. has moved from attractive to fair. The company appears to be overvalued based on its current metrics, particularly with a P/E ratio of 29, which is significantly higher than its peer average of 20.46. Additionally, the EV to EBITDA ratio stands at 15.24, while the industry average is much lower, indicating a premium valuation. The PEG ratio of 5.85 also suggests that the stock may be overvalued relative to its growth prospects.<BR><BR>In comparison to its peers, Align Technology, Inc. is less favorable, with its EV to EBIT ratio of 18.76 compared to a peer average of 11.41. The company's recent stock performance has been notably poor, with a year-to-date return of -37.44%, starkly contrasting with the S&P 500's positive return of 13.30% during the same period. This underperformance reinforces the view that Align Technology, Inc. is currently overvalued.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

High Management Efficiency with a high ROE of 12.95%

 
2

Company has a low Debt to Equity ratio (avg) at times

 
3

Poor long term growth as Operating profit has grown by an annual rate 18.90% of over the last 5 years

 
4

Flat results in Jun 25

5

With ROE of 11.95%, it has a fair valuation with a 3.45 Price to Book Value

6

High Institutional Holdings at 100%

7

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 9,920 Million (Small Cap)

stock-summary
P/E

29.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.22

stock-summary
Return on Equity

12.39%

stock-summary
Price to Book

2.54

Revenue and Profits:
Net Sales:
1,012 Million
(Quarterly Results - Jun 2025)
Net Profit:
125 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
18.5%
0%
18.5%
6 Months
-12.46%
0%
-12.46%
1 Year
-32.98%
0%
-32.98%
2 Years
-28.85%
0%
-28.85%
3 Years
-20.95%
0%
-20.95%
4 Years
-74.69%
0%
-74.69%
5 Years
-69.31%
0%
-69.31%

Align Technology, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
12.91%
EBIT Growth (5y)
18.90%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
1.03
Tax Ratio
30.70%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
25.44%
ROE (avg)
12.95%
Valuation key factors
Factor
Value
P/E Ratio
29
Industry P/E
Price to Book Value
3.45
EV to EBIT
18.76
EV to EBITDA
15.24
EV to Capital Employed
4.15
EV to Sales
3.08
PEG Ratio
5.85
Dividend Yield
NA
ROCE (Latest)
22.11%
ROE (Latest)
11.95%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 160 Schemes (48.37%)

Foreign Institutions

Held by 403 Foreign Institutions (25.6%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 3.38% vs -1.60% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 33.69% vs -10.21% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,012.40",
          "val2": "979.30",
          "chgp": "3.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "203.60",
          "val2": "174.40",
          "chgp": "16.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-27.10",
          "val2": "-15.70",
          "chgp": "-72.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "124.60",
          "val2": "93.20",
          "chgp": "33.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "161.00%",
          "val2": "138.10%",
          "chgp": "2.29%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 3.54% vs 3.42% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -5.32% vs 23.09% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,999.00",
          "val2": "3,862.30",
          "chgp": "3.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "816.80",
          "val2": "799.10",
          "chgp": "2.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-28.90",
          "val2": "-13.30",
          "chgp": "-117.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "421.40",
          "val2": "445.10",
          "chgp": "-5.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "168.00%",
          "val2": "170.00%",
          "chgp": "-0.20%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
1,012.40
979.30
3.38%
Operating Profit (PBDIT) excl Other Income
203.60
174.40
16.74%
Interest
0.00
0.00
Exceptional Items
-27.10
-15.70
-72.61%
Consolidate Net Profit
124.60
93.20
33.69%
Operating Profit Margin (Excl OI)
161.00%
138.10%
2.29%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 3.38% vs -1.60% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 33.69% vs -10.21% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
3,999.00
3,862.30
3.54%
Operating Profit (PBDIT) excl Other Income
816.80
799.10
2.21%
Interest
0.00
0.00
Exceptional Items
-28.90
-13.30
-117.29%
Consolidate Net Profit
421.40
445.10
-5.32%
Operating Profit Margin (Excl OI)
168.00%
170.00%
-0.20%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 3.54% vs 3.42% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -5.32% vs 23.09% in Dec 2023

stock-summaryCompany CV
About Align Technology, Inc. stock-summary
stock-summary
Align Technology, Inc.
Pharmaceuticals & Biotechnology
Align Technology, Inc. designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment. The Clear Aligner segment consists of its Invisalign System, which includes Invisalign Full, Teen and Assist (Comprehensive Products), Express/Lite (Non-Comprehensive Products) and Vivera Retainers, along with its training and ancillary products for treating malocclusion (Non-Case). The Scanner segment consists of intra-oral scanning systems and other services available with the intra-oral scanners that provide digital alternatives to the traditional cast models. The Scanner segment includes its iTero scanner and OrthoCAD services.
Company Coordinates stock-summary
Company Details
2820 Orchard Pkwy , SAN JOSE CA : 95134-2019
stock-summary
Tel: 1 408 47010001 408 4701150
stock-summary
Registrar Details